NOV 01, 2017 9:00 AM PDT

WEBINAR: Clinical Applications and Strategies Using Procalcitonin (PCT) to Improve Patient Outcomes

Speaker
  • Director of Critical Services Swedish Covenant Hospital
    Biography
      Eric Howard Gluck, M.D. received his medical degree in medicine from New York Medical College in Valhalla, New York. He completed his residency at Beth Israel Medical Center in New York City and a pulmonary fellowship at the University of Utah School of Medicine in Salt Lake City, Utah. He currently serves as the director of Critical Care Services and Chief Academic Officer at Swedish Covenant Hospital in Chicago, Illinois. In addition, Dr. Gluck is a Professor of Medicine at the Finch University of Health Sciences/The Chicago Medical School. Dr. Gluck is part of many professional societies. Most notably, he is a fellow of the Society of Critical Care Medicine, the American College of Chest Physicians, and the Chicago Institute of Medicine. He is a member of the American Thoracic Society, the Society of Sigma Xi, Alpha Omega Alpha, and the American Society of Law, Medicine, and Ethics. He has presented lectures and authored many peer reviewed articles and chapters in the field of pulmonary critical care and has been in practice for more than 20 years. More recently, Dr. Gluck has been leader at developing and implementation strategies at his institution to reduce the risk of sepsis in critically ill patients.

    Abstract

    DATE:  November 1, 2017

    TIME:  9:00am PT, 12:00pm ET

    Over 1.6 million people are diagnosed with sepsis in the U.S. each year1 and sepsis is the #1 cost of hospitalization (over $24 billion each year)1. Having a biomarker that can quickly identify sepsis is critical because mortality increases 8% every hour that treatment is delayed1.

    Procalcitonin (PCT) helps determine if the patient has a bacterial infection (sepsis), the severity of the infection and is the patient responding to therapy2. PCT is a more accurate diagnostic parameter for sepsis and a better predictor of mortality and a more reliable marker than other biomarkers3. PCT also provides clinicians a mechanism for antibiotic stewardship2.

    1. Sepsis Alliance Website: http://www.sepsis.org/downloads/2017_sepsis_facts_media.pdf3
    2. Thermo Scientific B-R-A-H-M-S PCT Improving infection management.
    3. Shiferaw, et al. The Role of Procalcitonin as a Biomarker in Sepsis. J Infect Dis Epidemiology. 2016;2:006 Vol 2.

    Expected Outcomes:

    • Understand the clinical utility of PCT.
    • Incorporate  PCT protocols as part of sepsis management.
    • Demonstrate the impact PCT can have on clinical and financial outcomes

     


    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    Loading Comments...
    Show Resources
    Attendees
    • See more